Literature DB >> 26191233

Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis.

Hyun-Soo Kim1, Gun Yoon2, Yoo-Young Lee3, Tae-Joong Kim3, Chel-Hun Choi3, Jeong-Won Lee3, Byoung-Gie Kim3, Duk-Soo Bae3, Sang Yong Song4.   

Abstract

Benign lymph node inclusions are commonly encountered during surgery for gynecologic neoplasms and are potential mimics of metastatic tumor. The presence of mesothelial cell inclusions in pelvic lymph nodes is extremely rare. We report the clinicopathologic features of 10 patients with ovarian tumors and mesothelial cell inclusions detected in the sinuses of pelvic and paraaortic lymph nodes. All patients had concurrent massive ascites and mesothelial cell hyperplasia at the time of lymph node dissection. Histologically, nodal mesothelial cells were identified predominantly within the subcapsular, trabecular and medullary sinuses. Moreover, intra- and extranodal lymphatics also contained mesothelial cells, confirming their mode of lymphatic transport to nodal sinuses. This finding, together with mesothelial cell hyperplasia and massive ascites suggest that mesothelial cells derive from reactive serosal mesothelium and are dislodged into draining lymphatics. This study indicated the pathogenic significance of the lymphatic transport mechanism. Nodal mesothelial cell inclusions should be distinguished from metastatic tumor to avoid inaccurate staging in a patient with a known tumor or the false negative diagnosis of an occult primary tumor. Recognition of this entity by immunohistochemical evaluation in addition to routinely stained sections is important to prevent a diagnosis of metastatic carcinoma or malignant mesothelioma.

Entities:  

Keywords:  Mesothelial cell; ascites; inclusion; lymph node; metastatic carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26191233      PMCID: PMC4503104     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

1.  Hyperplastic mesothelial cells in mediastinal lymph node sinuses with extranodal lymphatic involvement.

Authors:  P A Isotalo; J P Veinot; M Jabi
Journal:  Arch Pathol Lab Med       Date:  2000-04       Impact factor: 5.534

2.  Images in pathology. Benign hyperplastic mesothelial cells in lymph node.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Juan Rosai
Journal:  Int J Surg Pathol       Date:  2007-07       Impact factor: 1.271

3.  Benign mesothelial cells as confounders when cytokeratin immunohistochemistry is used in sentinel lymph nodes.

Authors:  Andrew Colebatch; Adele Clarkson; Anthony J Gill
Journal:  Hum Pathol       Date:  2011-06-12       Impact factor: 3.466

4.  Mesothelial pelvic lymph node inclusions mimicking metastatic thyroid carcinoma.

Authors:  D E Cohn; A L Folpe; A M Gown; B A Goff
Journal:  Gynecol Oncol       Date:  1998-02       Impact factor: 5.482

5.  Hyperplastic mesothelial cells in lymph nodes: report of six cases of a benign process that can stimulate metastatic involvement by mesothelioma or carcinoma.

Authors:  P Argani; J Rosai
Journal:  Hum Pathol       Date:  1998-04       Impact factor: 3.466

6.  Mesothelial cell inclusions within mediastinal lymph nodes.

Authors:  G N Rutty; I Lauder
Journal:  Histopathology       Date:  1994-11       Impact factor: 5.087

7.  Benign mesothelial cells in mediastinal lymph nodes.

Authors:  V Parkash; M Vidwans; D Carter
Journal:  Am J Surg Pathol       Date:  1999-10       Impact factor: 6.394

8.  Mesothelial cell inclusions mimicking adenocarcinoma in cervical lymph nodes in association with chylous effusion.

Authors:  Manu Goyal; Suseela Kodandapani; S Nirni Sharanabasappa; Satya Dattatreya Palanki
Journal:  Indian J Med Paediatr Oncol       Date:  2010-04

9.  Glandular inclusions in lymph nodes. The problem of extensive involvement and relationship to salpingitis.

Authors:  S M Kheir; W J Mann; J A Wilkerson
Journal:  Am J Surg Pathol       Date:  1981-06       Impact factor: 6.394

10.  Hyperplastic mesothelial cells in pelvic and abdominal lymph node sinuses mimicking metastatic ovarian microinvasive serous borderline tumor.

Authors:  G Kir; S Eren; M Kir
Journal:  Eur J Gynaecol Oncol       Date:  2004       Impact factor: 0.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.